Table 3.

Age-adjusted ORs and 95% CIs for AMH quartiles and prostate cancer risk restricted to the subpopulation with PSA < 4.0 ng/mL at baseline

Cases
AMH quartiles (ng/mL)ControlsTotalAggressiveaNonaggressiveb
Q1 (0.04–2.64)2321421.00 (reference)561.00 (reference)791.00 (reference)
Q2 (2.65–4.21)2331651.15 (0.86–1.54)751.35 (0.91–1.99)891.10 (0.77–1.57)
Q3 (4.22–6.74)2411631.10 (0.82–1.46)671.17 (0.78–1.74)951.13 (0.79–1.60)
Q4 (6.75–25.0)2421911.27 (0.96–1.69)671.19 (0.79–1.77)1211.42 (1.01–1.99)
Ptrend0.1350.7130.035

NOTE: There were 12 prostate cancer cases that could not be classified to a subtype due to missing tumor characteristics.

  • aAggressive prostate cancer: biopsy Gleason ≥ 7, or clinical stage ≥III, or fatal.

  • bNonaggressive prostate cancer: biopsy Gleason ≤ 6, and clinical stage = I or II.